Physician profile
James C Wang
NPI 1225490840
$21,399.01
in general payments reported to CMS, 2019-2025
26 companies · $3,254 in 2025
The $3,254 reported for 2025 was more than what 95% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $895 · 2020: $66.27 · 2021: $3,308 · 2022: $4,524 · 2023: $3,922 · 2024: $5,429 · 2025: $3,254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $747 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,838.19 |
| Travel and Lodging | $747.25 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,708.98 | 2019-2025 | Na, Smartlock, Vsp System, Vsp Cranial |
| Aerin Medical INC. | $3,471.45 | 2019-2025 | |
| Integra Lifesciences Corporation | $2,419.86 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Organogenesis INC. | $2,389.27 | 2023-2025 | Puraply, Via Matrix, Puraply Franchise |
| Axogen | $2,093.92 | 2022-2025 | Avance Nerve Graft, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Inspire Medical Systems, INC. | $1,356.26 | 2021 | |
| Depuy Synthes Sales INC. | $1,024.22 | 2021-2025 | Trumatch, Matrixmandible, Matrixmidface |
| Smith+Nephew, INC. | $646.14 | 2022-2024 | Stravix Pl, Oasis, Stravix |
| Checkpoint Surgical, INC | $591.40 | 2020-2024 | Checkpoint Stimulators |
| Medical Device Business Services, INC. | $578.49 | 2019-2021 | |
| Abbvie INC. | $354.88 | 2024-2025 | |
| Mimedx Group, INC. | $266.75 | 2024 | |
| Spirair, INC. | $256.08 | 2024 | Septalign |
| Polynovo North America LLC | $174.58 | 2025 | Novosorb Btm |
| Medtronic, INC. | $144.71 | 2024 | Novapak |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $143.43 | 2025 | Restrata Wound Matrix |
| Acclarent, INC | $126.72 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $124.21 | 2023 | Dupixent |
| Glaxosmithkline, LLC. | $116.40 | 2019 | |
| Kls-Martin L.P. | $107.75 | 2024 | |
| Ambu INC. | $104.16 | 2024 | |
| Cochlear Americas | $80.40 | 2021 | |
| Novartis Pharmaceuticals Corporation | $50.00 | 2019 | |
| Cook Medical LLC | $28.86 | 2022 | |
| Alexion Pharmaceuticals, INC. | $25.48 | 2025 | Ultomiris |
| Scilex Pharmaceuticals INC. | $14.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.